Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

From the World Literature

From the World Literature Am J Cardiovasc Drugs 2001; 1 (4) 305-313 1175-3277/01/0004-0305/$22.00/0 © Adis International Limited. All rights reserved. The ATP III guidelines include a set of recommendations US NCEP Issues ATP III Guidelines specifically targeting women and older adults. The third report of the US National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and More Aggressive Therapy T r e a t ment of High Blood Cholesterol in Adults, otherwise known as the Adult Treatment Panel (ATP) III, has been The ATP III guidelines recommend initiating cholesterol- [1] released. Compared with the ATP II guidelines, which were lowering drug therapy with an HMG CoA reductase inhibitor published in 1993, the updated guidelines expand the indica- (statin), bile acid sequestrant or nicotinic acid. If the goal LDL- tions for intensive cholesterol-lowering therapy in clinical cholesterol level has not been met after 6 weeks of therapy, drug practice. dosages should be increased or another drug therapy should be added to the treatment regimen. If the goal LDL-cholesterol level has not been met after 12 weeks, drug therapy should be Focus on Multiple Risk Factors intensified or other risk factors should be treated. Of note, the guidelines recommend against the use of http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Cardiovascular Drugs Springer Journals

From the World Literature

American Journal of Cardiovascular Drugs , Volume 1 (4) – Aug 17, 2012
Download PDF
9 pages

Loading next page...
 
/lp/springer-journals/from-the-world-literature-Rty03WXV70

References (30)

Publisher
Springer Journals
Copyright
Copyright © 2001 by Adis International Limited
Subject
Medicine & Public Health; Cardiology; Pharmacotherapy; Pharmacology/Toxicology
ISSN
1175-3277
eISSN
1179-187X
DOI
10.2165/00129784-200101040-00008
Publisher site
See Article on Publisher Site

Abstract

Am J Cardiovasc Drugs 2001; 1 (4) 305-313 1175-3277/01/0004-0305/$22.00/0 © Adis International Limited. All rights reserved. The ATP III guidelines include a set of recommendations US NCEP Issues ATP III Guidelines specifically targeting women and older adults. The third report of the US National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and More Aggressive Therapy T r e a t ment of High Blood Cholesterol in Adults, otherwise known as the Adult Treatment Panel (ATP) III, has been The ATP III guidelines recommend initiating cholesterol- [1] released. Compared with the ATP II guidelines, which were lowering drug therapy with an HMG CoA reductase inhibitor published in 1993, the updated guidelines expand the indica- (statin), bile acid sequestrant or nicotinic acid. If the goal LDL- tions for intensive cholesterol-lowering therapy in clinical cholesterol level has not been met after 6 weeks of therapy, drug practice. dosages should be increased or another drug therapy should be added to the treatment regimen. If the goal LDL-cholesterol level has not been met after 12 weeks, drug therapy should be Focus on Multiple Risk Factors intensified or other risk factors should be treated. Of note, the guidelines recommend against the use of

Journal

American Journal of Cardiovascular Drugs – Springer Journals

Published: Aug 17, 2012

There are no references for this article.